The Asia Pacific Tranexamic Acid market size was valued at US$ 156.3 million in 2024 and is projected to reach US$ 204.7 million by 2030, at a CAGR of 4.6% during the forecast period 2024-2030.

Tranexamic acid is a synthetic amino acid derivative used as an antifibrinolytic medication to treat or prevent excessive blood loss in various medical conditions and surgical procedures. As healthcare systems across the Asia Pacific region continue to advance, with rising surgical volumes and greater emphasis on effective bleeding control, the spotlight is on the key manufacturers and suppliers who are driving innovation, accessibility, and quality in this essential therapeutic area. In this blog, we profile the Top 10 Companies in the Asia Pacific Tranexamic Acid Market—a mix of regional pharmaceutical leaders and global players shaping the future of antifibrinolytic therapies.

---

🔟 1. Jiangsu Wanbang Biochemical Pharmaceutical Co., Ltd.

Headquarters: Xuzhou, Jiangsu, China
Key Offering: Tranexamic Acid API and Formulations

Jiangsu Wanbang Biochemical Pharmaceutical, part of Fosun Pharma, is a significant producer of pharmaceutical ingredients and finished dosage forms in China. The company focuses on high-quality manufacturing standards and supplies antifibrinolytic agents to meet growing domestic and regional demand for surgical and trauma care applications.

Initiatives:

• Expansion of sterile production capabilities

• Focus on metabolic and related therapeutic areas supporting broader hospital supply

• Commitment to quality certifications for international markets

Download FREE Sample Report: Asia Pacific Tranexamic Acid Market – View in Detailed Research Report

---

9️⃣ 2. Emcure Pharmaceuticals Ltd.

Headquarters: Pune, India
Key Offering: Tranexamic Acid Tablets and Injections (Pause brand)

Emcure Pharmaceuticals is a prominent Indian player with a strong presence in hospital and specialty generics. Its Pause range of tranexamic acid products is widely used for managing menorrhagia, surgical bleeding, and postpartum hemorrhage across India and select export markets.

Initiatives:

• Strengthening injectables manufacturing capacity

• Partnerships for hospital channel distribution

---

8️⃣ 3. Daiichi Sankyo Company, Limited (Nippon Pharmaceutical)

Headquarters: Tokyo, Japan
Key Offering: Transamin (Tranexamic Acid) Formulations

Daiichi Sankyo has a long history with tranexamic acid, having developed and commercialized Transamin in Japan. The company maintains leadership in the Japanese market for both therapeutic and cosmetic-related applications of the molecule.

Initiatives:

• Ongoing research into established hemostatic therapies

• Development of accessible OTC and prescription options

Download FREE Sample Report: Asia Pacific Tranexamic Acid Market – View in Detailed Research Report

---

7️⃣ 4. Zydus Cadila

Headquarters: Ahmedabad, India
Key Offering: Tranexamic Acid Tablets and Injectables

Zydus Cadila is a major generic pharmaceutical manufacturer with extensive capabilities in producing high-volume APIs and formulations. The company supplies tranexamic acid products to domestic hospitals and international markets, supporting cost-effective healthcare solutions.

Initiatives:

• Vertical integration in API production

• Expansion of specialty generics portfolio

---

6️⃣ 5. Hikma Pharmaceuticals PLC

Headquarters: London, United Kingdom (with strong Asia Pacific operations)
Key Offering: Generic Tranexamic Acid Injectables

Hikma provides reliable supply of injectable tranexamic acid to hospitals across multiple regions, including growing Asia Pacific markets. The company emphasizes quality and consistent availability for critical care applications.

Initiatives:

• Focus on hospital generics and injectables

• Supply chain optimization for emerging markets

Download FREE Sample Report: Asia Pacific Tranexamic Acid Market – View in Detailed Research Report

---

5️⃣ 6. Zhejiang Huayi Pharmaceutical Co., Ltd.

Headquarters: Zhejiang Province, China
Key Offering: Tranexamic Acid API and Intermediates

Zhejiang Huayi is an active participant in the API manufacturing landscape, contributing to the regional supply of tranexamic acid raw materials that support formulation manufacturers across Asia Pacific.

Initiatives:

• Compliance with international quality standards

• Capacity enhancements for key intermediates

---

4️⃣ 7. Micro Labs Ltd

Headquarters: Bangalore, India
Key Offering: Tranexamic Acid Oral and Injectable Products

Micro Labs has built a solid reputation in the Indian pharmaceutical market with a focus on quality generics. Its tranexamic acid offerings cater to gynecological, surgical, and trauma care segments.

Initiatives:

• Investment in R&D for differentiated formulations

• Strong distribution network in key Indian states

---

3️⃣ 8. Shanxi Kangbao Biological Product Co., Ltd

Headquarters: Shanxi Province, China
Key Offering: Biological-derived and Synthetic Pharmaceutical Products including Tranexamic Acid

Shanxi Kangbao contributes to the supply chain with specialized manufacturing expertise, supporting the availability of tranexamic acid in northern China and surrounding areas.

Initiatives:

• Focus on biological and synthetic integration

• Regional healthcare supply reliability

Download FREE Sample Report: Asia Pacific Tranexamic Acid Market – View in Detailed Research Report

---

2️⃣ 9. Olon S.p.A.

Headquarters: Milan, Italy (with Asia Pacific supply chains)
Key Offering: High-Purity Tranexamic Acid API

Olon is a global leader in API development and manufacturing, providing premium quality tranexamic acid to formulators operating in the Asia Pacific region.

Initiatives:

• Advanced synthesis technologies

• Regulatory compliance for multiple markets

---

1️⃣ 10. Sanghai Lonyer Fuels Co., Ltd (associated pharmaceutical operations)

Headquarters: Shanghai, China
Key Offering: Chemical and Pharmaceutical Intermediates leading to Tranexamic Acid

This Shanghai-based entity supports the chemical foundation for pharmaceutical production, playing a role in the upstream supply for tranexamic acid manufacturing in the region.

Initiatives:

• Process optimization for key molecules

• Contribution to local pharmaceutical ecosystem

Read Full Report: Asia Pacific Tranexamic Acid Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Tranexamic Acid in Asia Pacific Is More Accessible and Effective

The Asia Pacific Tranexamic Acid market is experiencing steady expansion driven by increasing surgical procedures, improved trauma care, and greater awareness of its benefits in obstetrics and gynecology. While traditional applications continue to dominate, the industry is seeing growing interest in cosmetic dermatology uses and novel delivery formats.

📈 Key Trends Shaping the Market:

• Rising demand from expanding healthcare infrastructure in emerging economies

• Increased adoption in postpartum hemorrhage protocols

• Growth in generic manufacturing capabilities across India and China

• Focus on supply chain resilience for critical care medicines

Read Full Report: Asia Pacific Tranexamic Acid Market – View in Detailed Research Report

The companies listed above are not only supplying essential medication—they are supporting better patient outcomes across the diverse healthcare landscapes of Asia Pacific.